These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7586507)
21. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Hyman BT; West HL; Rebeck GW; Buldyrev SV; Mantegna RN; Ukleja M; Havlin S; Stanley HE Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3586-90. PubMed ID: 7724603 [TBL] [Abstract][Full Text] [Related]
22. Reduced transferrin binding in Down syndrome: a route to senile plaque formation and dementia. Hodgkins PS; Prasher V; Farrar G; Armstrong R; Sturman S; Corbett J; Blair JA Neuroreport; 1993 Oct; 5(1):21-4. PubMed ID: 8280853 [TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Namba Y; Tomonaga M; Kawasaki H; Otomo E; Ikeda K Brain Res; 1991 Feb; 541(1):163-6. PubMed ID: 2029618 [TBL] [Abstract][Full Text] [Related]
24. Excessive expression of synaptojanin in brains with Down syndrome. Arai Y; Ijuin T; Takenawa T; Becker LE; Takashima S Brain Dev; 2002 Mar; 24(2):67-72. PubMed ID: 11891094 [TBL] [Abstract][Full Text] [Related]
25. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome. Ikeda S; Allsop D; Glenner GG Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370 [TBL] [Abstract][Full Text] [Related]
26. Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs. Azizeh BY; Head E; Ibrahim MA; Torp R; Tenner AJ; Kim RC; Lott IT; Cotman CW Exp Neurol; 2000 May; 163(1):111-22. PubMed ID: 10785449 [TBL] [Abstract][Full Text] [Related]
27. Developmental changes of heat shock protein 73 in human brain. Kato M; Mizuguchi M; Takashima S Brain Res Dev Brain Res; 1995 May; 86(1-2):180-6. PubMed ID: 7656411 [TBL] [Abstract][Full Text] [Related]
28. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622 [TBL] [Abstract][Full Text] [Related]
29. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Hyman BT; West HL; Rebeck GW; Lai F; Mann DM Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373 [TBL] [Abstract][Full Text] [Related]
30. Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Cheon MS; Dierssen M; Kim SH; Lubec G Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181 [TBL] [Abstract][Full Text] [Related]
31. Upregulation of phosphorylated alphaB-crystallin in the brain of children and young adults with Down syndrome. Palminiello S; Jarząbek K; Kaur K; Walus M; Rabe A; Albertini G; Golabek AA; Kida E Brain Res; 2009 May; 1268():162-173. PubMed ID: 19272359 [TBL] [Abstract][Full Text] [Related]
32. Developmental immunohistochemistry of membrane proteins in the brain coded by a gene on human chromosome 21. Takashima S; Kuruta H; Mito T; Konomi H; Obata R; Onodera K Brain Res Dev Brain Res; 1990 May; 53(2):295-8. PubMed ID: 2141555 [TBL] [Abstract][Full Text] [Related]
33. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Griffin WS; Stanley LC; Ling C; White L; MacLeod V; Perrot LJ; White CL; Araoz C Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7611-5. PubMed ID: 2529544 [TBL] [Abstract][Full Text] [Related]
34. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. Landén M; Thorsell A; Wallin A; Blennow K J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772 [TBL] [Abstract][Full Text] [Related]
35. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Iwatsubo T; Mann DM; Odaka A; Suzuki N; Ihara Y Ann Neurol; 1995 Mar; 37(3):294-9. PubMed ID: 7695229 [TBL] [Abstract][Full Text] [Related]
36. High expression on Kunitz-type protease inhibitor-containing substances in the cerebral vessels of patients with Down syndrome. Suzuki A; Takashima S; Mizuguchi M; Kato M; Kunishita T; Tabira T Tohoku J Exp Med; 1994 Nov; 174(3):181-7. PubMed ID: 7761983 [TBL] [Abstract][Full Text] [Related]
37. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882 [TBL] [Abstract][Full Text] [Related]
38. Developmental expression of alpha 1-antichymotrypsin in brain may be related to astrogliosis. Koo EH; Abraham CR; Potter H; Cork LC; Price DL Neurobiol Aging; 1991; 12(5):495-501. PubMed ID: 1837594 [TBL] [Abstract][Full Text] [Related]
39. Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia. Motonaga K; Itoh M; Hirayama A; Hirano S; Becker LE; Goto Y; Takashima S Brain Res; 2001 Jun; 905(1-2):250-3. PubMed ID: 11423103 [TBL] [Abstract][Full Text] [Related]